Skip to main content
29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease
Read More
27 Jul 2020
UCB Half Year Report 2020: UCB’s resilient product portfolio drives continued company growth
Read More
24 Jul 2020
24 Jul 2020
Bimekizumab Superior to Cosentyx[®] in Achieving Complete Psoriasis Skin Clearance
Read More
23 Jul 2020
17 Jul 2020
10 Jul 2020
7 Jul 2020
UCB and Ferring Pharmaceuticals Announce Co-Promotion of CIMZIA[®] (certolizumab pegol) for the Treatment of Adults with Moderate to Severe Crohn’s Disease
Read More
3 Jul 2020
26 Jun 2020
Subscribe to
